Pharmacology of Cinoxacin in Humans
Open Access
- 1 February 1979
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 15 (2) , 165-170
- https://doi.org/10.1128/aac.15.2.165
Abstract
Cinoxacin was almost completely absorbed when given orally and was found to be approximately 60 to 70% protein bound. Peak serum concentrations were reached within 2 h, and detectable serum concentrations persisted up to 12 h after administration of 0.25-, 0.5-, and 1-g multiple oral doses. Although food delayed the absorption and caused a 30% reduction in mean peak serum concentrations, the overall 24-h urinary recovery was not significantly altered. Approximately 50 to 55% of the drug was excreted in the urine as unchanged drug. At 12 h, urine concentrations were still above the minimal inhibitory concentration for most common gram-negative urinary pathogens. Cinoxacin was well tolerated when administered to 23 volunteers from 10 to 28 days. Resistance among fecal isolates initially susceptible to cinoxacin was not observed in nine volunteers who were administered 0.5 g every 12 h for 4 to 28 days.This publication has 14 references indexed in Scilit:
- Studies on cinoxainJournal of Antimicrobial Chemotherapy, 1977
- Management of simple ureterolithotomy closureUrology, 1977
- Studies on cinoxacinJournal of Antimicrobial Chemotherapy, 1977
- Studies on cinoxacinJournal of Antimicrobial Chemotherapy, 1977
- Cinoxacin concentrations in Plasma, Urine and Prostatic Tissue after Oral Administration to ManBritish Journal of Urology, 1977
- In Vitro Antimicrobial Activity of Cinoxacin Against 2,968 Clinical Bacterial IsolatesAntimicrobial Agents and Chemotherapy, 1976
- Antibacterial Activity of Cinoxacin In VitroAntimicrobial Agents and Chemotherapy, 1975
- In Vitro Activity of Cinoxacin, an Organic Acid AntibacterialAntimicrobial Agents and Chemotherapy, 1975
- Cinoxacin: In Vitro Antibacterial Studies of a New Synthetic Organic AcidAntimicrobial Agents and Chemotherapy, 1975
- Compound 64716, a New Synthetic Antibacterial AgentAntimicrobial Agents and Chemotherapy, 1973